Edwards SAPIEN™ Aortic Bioprosthesis Multi-Region Outcome Registry XT
Edwards SAPIEN™ Aortic Bioprosthesis Multi-Region Outcome Registry XT
This registry is to expand upon existing data sets, to identify patient characteristics and indicators related to complications and clinical benefits for patients with symptomatic severe calcific degenerative aortic stenosis that are undergoing treatment with the commercially available Edwards SAPIEN XT™ Valve, and delivery devices.
Consecutive patient data should be collected at discharge, 30 days and 12 months post-implant. Subsets of patients may undergo additional follow-up.
Inclusion Criteria:
Exclusion Criteria:
Bad Oyenhausen, 32545, Germany
Rozzano Milano, 20089, Italy
Grand Rapids, 7506, South Africa
London, W12 0HS, United Kingdom